Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia.

Medeiros BC, Othus M, Estey EH, Fang M, Appelbaum FR.

Br J Haematol. 2014 Jan;164(2):245-50. doi: 10.1111/bjh.12625. Epub 2013 Oct 28.

PMID:
24383844
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.

Lazarevic V, Hörstedt AS, Johansson B, Antunovic P, Billström R, Derolf A, Lehmann S, Möllgård L, Peterson S, Stockelberg D, Uggla B, Vennström L, Wahlin A, Höglund M, Juliusson G.

Eur J Haematol. 2014 Sep 8. doi: 10.1111/ejh.12446. [Epub ahead of print]

PMID:
25200361
[PubMed - as supplied by publisher]
3.

Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.

Gangatharan SA, Grove CS, P'ng S, O'Reilly J, Joske D, Leahy MF, Threlfall T, Wright MP.

Intern Med J. 2013 Aug;43(8):903-11. doi: 10.1111/imj.12169.

PMID:
23611681
[PubMed - indexed for MEDLINE]
4.

Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?

Ferrara F.

Hematol Oncol. 2014 Mar;32(1):1-9. doi: 10.1002/hon.2046. Epub 2013 Mar 20. Review.

PMID:
23512815
[PubMed - indexed for MEDLINE]
5.

Significance of cytogenetic abnormalities in acute myeloid leukaemia.

Harani MS, Adil SN, Kakepoto GN, Khilji Z, Shaikh U, Khurshid M.

J Pak Med Assoc. 2006 Jan;56(1):9-13.

PMID:
16454127
[PubMed - indexed for MEDLINE]
6.

Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.

Chalandon Y, Barnett MJ, Horsman DE, Conneally EA, Nantel SH, Nevill TJ, Nitta J, Shepherd JD, Sutherland HJ, Toze CL, Hogge DE.

Biol Blood Marrow Transplant. 2002;8(8):435-43.

PMID:
12234169
[PubMed - indexed for MEDLINE]
7.

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

Nahi H, Lehmann S, Bengtzen S, Jansson M, Möllgård L, Paul C, Merup M.

Leuk Lymphoma. 2008 Mar;49(3):508-16. doi: 10.1080/10428190701861645.

PMID:
18297528
[PubMed - indexed for MEDLINE]
8.

Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.

Mi Y, Xue Y, Yu W, Liu S, Zhao Y, Meng Q, Bian S, Wang J.

Leuk Lymphoma. 2008 Mar;49(3):524-30. doi: 10.1080/10428190701836852.

PMID:
18297530
[PubMed - indexed for MEDLINE]
9.

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution.

Hirsch P, Labopin M, Viguié F, Perot C, Isnard F, Mamez AC, Bilhou-Nabera C, Marzac C, Delhommeau F, Lapusan S, Marie JP, Mohty M, Legrand O.

Leuk Res. 2014 Aug;38(8):907-12. doi: 10.1016/j.leukres.2014.05.021. Epub 2014 Jun 4.

PMID:
24957411
[PubMed - indexed for MEDLINE]
10.

Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.

Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR.

Blood. 2010 Sep 30;116(13):2224-8. doi: 10.1182/blood-2010-02-270330. Epub 2010 Jun 18.

PMID:
20562328
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.

Gröschel S, Lugthart S, Schlenk RF, Valk PJ, Eiwen K, Goudswaard C, van Putten WJ, Kayser S, Verdonck LF, Lübbert M, Ossenkoppele GJ, Germing U, Schmidt-Wolf I, Schlegelberger B, Krauter J, Ganser A, Döhner H, Löwenberg B, Döhner K, Delwel R.

J Clin Oncol. 2010 Apr 20;28(12):2101-7. doi: 10.1200/JCO.2009.26.0646. Epub 2010 Mar 22.

PMID:
20308656
[PubMed - indexed for MEDLINE]
Free Article
12.

Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR, Zemanova Z, Stary J, Bourquin JP, Haas OA, Dworzak MN, Creutzig U.

J Clin Oncol. 2010 Jun 1;28(16):2682-9. doi: 10.1200/JCO.2009.25.6321. Epub 2010 May 3.

PMID:
20439630
[PubMed - indexed for MEDLINE]
Free Article
13.

[Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].

Jarosová M, Indrák K, Holzerová M, Hubácek J, Faber E, Papajík T, Raida L, Szotkowski T, Knotková R, Hlusí T, Jedlicková K, Pikalová Z, Sulovská I.

Vnitr Lek. 2001 Sep;47 Suppl 1:8-14. Czech.

PMID:
11693065
[PubMed - indexed for MEDLINE]
14.

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A.

Blood. 1998 Oct 1;92(7):2322-33.

PMID:
9746770
[PubMed - indexed for MEDLINE]
Free Article
15.

Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.

Balleisen S, Kuendgen A, Hildebrandt B, Haas R, Germing U.

Leuk Res. 2009 Sep;33(9):1189-93. doi: 10.1016/j.leukres.2009.03.004. Epub 2009 May 9.

PMID:
19428106
[PubMed - indexed for MEDLINE]
16.

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.

Schoch C, Haferlach T, Haase D, Fonatsch C, Löffler H, Schlegelberger B, Staib P, Sauerland MC, Heinecke A, Büchner T, Hiddemann W; German AML Cooperative Study Group.

Br J Haematol. 2001 Jan;112(1):118-26.

PMID:
11167792
[PubMed - indexed for MEDLINE]
17.

Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.

Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM, Head DR, Appelbaum FR, Willman CL.

Blood. 1997 May 1;89(9):3323-9.

PMID:
9129038
[PubMed - indexed for MEDLINE]
Free Article
18.

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ.

Cancer Res. 1998 Sep 15;58(18):4173-9.

PMID:
9751631
[PubMed - indexed for MEDLINE]
Free Article
19.

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ, Burnett AK; National Cancer Research Institute Adult Leukaemia Working Group.

Blood. 2010 Jul 22;116(3):354-65. doi: 10.1182/blood-2009-11-254441. Epub 2010 Apr 12.

PMID:
20385793
[PubMed - indexed for MEDLINE]
Free Article
20.

Long-term outcomes of de novo acute myeloid leukemia in Thai patients.

Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V.

J Med Assoc Thai. 2009 Sep;92(9):1143-9.

PMID:
19772172
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk